Krish Biotech Research Pvt. Ltd. (KBRPL) the changing times, there has been constant evolution in the drug development, market dynamics, nature and demand of drugs. We ensure that we at KBRPL offer the best solutions which are reliable and quality tested. KBRPL supports drug discovery program by conducting preclinical safety assessment toxicology studies. Don’t let your drug candidate lack in terms of safety assessment. We are having expertise in conducting safety and assessment studies in line with ICH, FDA Redbook, WHO, EMEA and Schedule Y. We extend our proficiency on to dose formulation analysis, bioanalytical chemistry sample assays for drug concentration, pathology and peer review services, specialized statistical analyses and to determine toxico-kinetic and pharmacokinetics. Routes of Administration: Dermal, intranasal, Intravaginal and intra-penile, Ocular. Oral (gavage, diet and capsule). Parenteral (intravenous, subcutaneous, intradermal, intramuscular and intraperitoneal) and Rectal. Our scientific experts have the capability for the additional parameters required at
pre¬clinical stage in like:
• Single dose studies
• Repeated dose studies
• Chronic Toxicity Studies
• DART Studies
• Immuno-toxicity studies
• Analytical Capabilities (like pre-formulation studies, API method development and validation, Bioanalytical method development and method validation).